JAGUAR HEALTH, INC. Operating Lease, Liability, Current
JAGUAR HEALTH, INC. (JAGX) had Operating Lease, Liability, Current of $219.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-19
- 2026-06-30: Operating Lease, Liability, Current $219.00K.
- 2026-03-31: Operating Lease, Liability, Current $261.00K.
- 2025-12-31: Operating Lease, Liability, Current $192.00K.
- 2025-09-30: Operating Lease, Liability, Current $226.00K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $219.00K 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $261.00K 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $192.00K 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $226.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $256.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $273.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $299.00K 10-K · filed 2026-04-07 | |
| 2024-09-30 | $368.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $416.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $469.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $348.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $526.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $515.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $503.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $483.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $418.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $390.00K 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $299.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $240.00K 10-K · filed 2023-03-24 | |
| 2021-09-30 | $297.00K 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $199.00K 10-Q · filed 2021-08-13 | |
| 2020-06-30 | $116.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $228.00K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $337.00K 10-K · filed 2021-03-31 | $336.65K 10-K · filed 2020-04-03 |
| 2019-09-30 | $442.02K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $425.75K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $521.79K 10-Q · filed 2019-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |